Pregnancy Related — Psychoeducation in Preventing Postpartum Depression According to Watson
Citation(s)
Chow R, Huang E, Li A, Li S, Fu SY, Son JS, Foster WG Appraisal of systematic reviews on interventions for postpartum depression: systematic review. BMC Pregnancy Childbirth. 2021 Jan 6;21(1):18. doi: 10.1186/s12884-020-03496-5.
Dennis CL, Dowswell T Psychosocial and psychological interventions for preventing postpartum depression. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD001134. doi: 10.1002/14651858.CD001134.pub3.
Forster DA, McLachlan HL, Rayner J, Yelland J, Gold L, Rayner S The early postnatal period: exploring women's views, expectations and experiences of care using focus groups in Victoria, Australia. BMC Pregnancy Childbirth. 2008 Jul 22;8:27. doi: 10.1186/1471-2393-8-27.
Lau Y, Htun TP, Wong SN, Tam WSW, Klainin-Yobas P Therapist-Supported Internet-Based Cognitive Behavior Therapy for Stress, Anxiety, and Depressive Symptoms Among Postpartum Women: A Systematic Review and Meta-Analysis. J Med Internet Res. 2017 Apr 28;19(4):e138. doi: 10.2196/jmir.6712.
Moshki M, Kharazmi A, Cheravi K, Beydokhti TB The prediction of postpartum depression: The role of the PRECEDE model and health locus of control. J Family Med Prim Care. 2015 Jul-Sep;4(3):454-60. doi: 10.4103/2249-4863.161354.
Sockol LE, Epperson CN, Barber JP Preventing postpartum depression: a meta-analytic review. Clin Psychol Rev. 2013 Dec;33(8):1205-17. doi: 10.1016/j.cpr.2013.10.004. Epub 2013 Oct 21.
Turkel MC, Watson J, Giovannoni J Caring Science or Science of Caring. Nurs Sci Q. 2018 Jan;31(1):66-71. doi: 10.1177/0894318417741116.
Based on the Watson Model for the Prevention of Postpartum Depression Impact of Psychoeducational Intervention
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
